KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Short-Term Debt issuances (2016 - 2025)

Zimmer Biomet Holdings has reported Short-Term Debt issuances over the past 9 years, most recently at $220.0 million for Q2 2025.

  • Quarterly results put Short-Term Debt issuances at $220.0 million for Q2 2025, up 388.89% from a year ago — trailing twelve months through Jun 2025 was $335.0 million (up 28.85% YoY), and the annual figure for FY2024 was -$50.0 million, up 84.62%.
  • Short-Term Debt issuances for Q2 2025 was $220.0 million at Zimmer Biomet Holdings, up from $45.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for ZBH hit a ceiling of $220.0 million in Q2 2025 and a floor of -$65.0 million in Q2 2023.
  • Median Short-Term Debt issuances over the past 4 years was $110.0 million (2022), compared with a mean of $106.9 million.
  • Biggest five-year swings in Short-Term Debt issuances: tumbled 154.17% in 2023 and later soared 388.89% in 2025.
  • Zimmer Biomet Holdings' Short-Term Debt issuances stood at $155.0 million in 2022, then crashed by 141.94% to -$65.0 million in 2023, then soared by 169.23% to $45.0 million in 2024, then skyrocketed by 388.89% to $220.0 million in 2025.
  • The last three reported values for Short-Term Debt issuances were $220.0 million (Q2 2025), $45.0 million (Q2 2024), and $70.0 million (Q1 2024) per Business Quant data.